A Therapeutic Pipeline
to expand the impact of our mission
SDT is a Platform Technology
SonALAsense is pursuing a pipeline of additional indications utilizing SDT to treat multiple tumor types.
While our initial focus is on aggressive brain tumors and our secondary focus is on tumors outside the brain, SONALA-001 in combination with MR-guided focused ultrasound has the potential to treat the majority of tumors of epithelial origin: gliomas, meningiomas, pancreatic, ovarian, gastric, bladder, skin, esophageal, lung, gall bladder, and breast cancer.